Psychedelic Medicine
Association
Psychedelic Medicine
Association
President, Psychedelic Medicine Association
Associate Professor & Medical Director of Rehabilitation Center for Pain Medicine; Associate Medical Director, Center for Psychedelic Research, UC San Diego Health
Joel Castellanos, MD is a board-certified physical medicine and rehabilitation and pain medicine physician, and serves as medical director of Inpatient Rehabilitation. Dr. Castellanos’ prime focus is improving function using an individualized approach. He is particularly interested in neuromodulation at various levels including spinal cord stimulation and peripheral nerve stimulation, interventional spine procedures, radiofrequency neurotomy, ultrasound-guided and fluoroscopically-guided procedures, and regenerative medicine such as platelet-rich plasma, stem cells, and Tenex (minimally invasive technology for treatment of chronic pain). He has specific clinical interests in pelvic pain, complex regional pain syndrome, phantom limb pain, and post-spinal cord injury pain syndromes. His research interests include altering nutrition as a means of treating chronic pain, neuromodulation for chronic painful conditions as well as the potential use of psychedelics for these conditions. An associate professor in the Department of Anesthesiology at UC San Diego School of Medicine, Dr. Castellanos instructs pain medicine fellows, as well as medical students, residents in their pain rotations. Dr. Castellanos completed his fellowship in pain medicine at UC San Diego School of Medicine. He completed residency training in physical medicine and rehabilitation at University of Michigan Medical School, where he also he completed a two-year program in healthcare administration. Dr. Castellanos earned his medical degree from University of Toledo College of Medicine in Ohio. He is board certified in physical medicine and rehabilitation and pain medicine
Founder & CEO, REMAP Therapeutics; Co-Founder & Research Lead, Psychedelics & Pain Association
A former chronic pain sufferer, Court Wing is the founder and CEO of REMAP Therapeutics and the co-founder of the Psychedelics & Pain Association. REMAP Therapeutics is devoted to the development of formal psychedelic rehabilitation sessions and cohesive best practices for many treatment-resistant chronic pain conditions.
Court is an accomplished performance and pain professional with 30 years of experience in maximizing the athletic performance of his clients, helping countless individuals overcome injuries to return to competition and daily life. He is a certified Z-Health Master Trainer, was co-founder of NYC’s first CrossFit, and was a live-in apprentice to the US Chief Instructor of Ki-Aikido.
In 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for major depressive disorder. By the end of his “dosing” day in the trial, he was in full remission, no longer qualifying for the diagnosis of depression. More astounding were the lateral benefits; he was also no longer suffering from low-to-moderate chronic pain and related neurological issues from previous injuries. Court’s commitment to further investigate the healing potential of psychedelics stems from his direct experience as a participant in this psilocybin trial. With his extensive experience in applied neurophysiology for pain and performance, he immediately realized psychedelics were going to completely change the way we are able to treat chronic pain & physical conditions.
President, Heroic Hearts Project
Jesse Gould is a former Army Ranger and a pioneer in psychedelic therapies for veterans. As Founder and President of the Heroic Hearts Project, he has spearheaded the research and acceptance of ayahuasca, ibogaine, ketamine, and psilocybin therapy programs for military veterans. Jesse has connected hundreds of veterans to psychedelic treatments, partnered with the world’s leading psychedelic centers, and is researching psychiatric applications with the University of Georgia, the University of Texas, Austin Dell Medical School, and Imperial College of London. His mission is to help military veterans struggling with mental trauma and spread awareness of the benefits that psychedelic therapies offer as an alternative treatment to pharmaceuticals. Jesse has spoken globally about the benefits of psychedelics on mental health and has been featured in the New York Times, the New Yorker, the Economist, and Forbes and is recognized as one of the most influential voices in psychedelics today. To date Heroic Hearts Project has raised over $10 million dollars and has served over 1,500 veterans and military spouses through psychedelic therapies.
Chief Medical Officer at Novamind/Co-founder at Cedar Psychiatry
Dr. Reid Robison is a board-certified psychiatrist and Chief Medical Officer at Novamind. Reid is co-founder at Cedar Psychiatry and serves as Medical Director of Center for Change, a top Eating Disorder program. He is currently the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad.
We often discuss psychedelics in the context of treating mental health conditions; however, we know that they are showing promise in physical conditions as well, in addition to those disease states that have both physical and mental components, like pain.
In this month’s webinar, we explore the potential of psychedelics in addressing pain, a condition that can significantly impact patients’ lives, especially when conventional treatments fall short.
Given the challenges in effectively treating pain, a key question emerges: can psychedelic therapies offer new solutions?
To help answer this, we gathered experts experienced in pain management and the use of psychedelics.
Our esteemed panelists will cover topics including:
…and much more!
As always, there will be ample time for audience Q&A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Tuesday, March 25th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.